Rockefeller Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-13,253
| Closed | -$2.43M | – | 3973 |
|
|
2021
Q2 | $2.43M | Buy |
13,253
+3,503
| +36% | +$643K | 0.01% | 668 |
|
|
2021
Q1 | $1.49M | Sell |
9,750
-218
| -2% | -$33.3K | 0.01% | 665 |
|
|
2020
Q4 | $1.56M | Buy |
9,968
+1,771
| +22% | +$276K | 0.01% | 582 |
|
|
2020
Q3 | $937K | Buy |
8,197
+554
| +7% | +$63.3K | 0.01% | 612 |
|
|
2020
Q2 | $858K | Sell |
7,643
-2,191
| -22% | -$246K | 0.01% | 576 |
|
|
2020
Q1 | $883K | Sell |
9,834
-1,831
| -16% | -$164K | 0.01% | 500 |
|
|
2019
Q4 | $1.26M | Buy |
11,665
+1,021
| +10% | +$110K | 0.02% | 412 |
|
|
2019
Q3 | $1.04M | Sell |
10,644
-310
| -3% | -$30.3K | 0.01% | 383 |
|
|
2019
Q2 | $1.43M | Sell |
10,954
-2,818
| -20% | -$369K | 0.02% | 297 |
|
|
2019
Q1 | $1.86M | Buy |
13,772
+2,785
| +25% | +$377K | 0.03% | 275 |
|
|
2018
Q4 | $1.07M | Buy |
10,987
+425
| +4% | +$41.4K | 0.02% | 239 |
|
|
2018
Q3 | $1.47M | Buy |
10,562
+1,986
| +23% | +$276K | 0.02% | 187 |
|
|
2018
Q2 | $1.07M | Buy |
8,576
+26
| +0.3% | +$3.23K | 0.02% | 206 |
|
|
2018
Q1 | $953K | Buy |
+8,550
| New | +$953K | 0.02% | 219 |
|